DVA · 10-Q · 2026Q2 · Full report

Capital Expenditures

DAVITA INC. · 2026-08-04 · Importance 36 · Surprise 14 · No source text

DaVita invested $271.8 million in property and equipment during the first six months of 2026, up 2.8% from $264.3 million in the prior-year period. U.S. dialysis capital expenditures were $229.5 million, compared with $216.9 million a year earlier, while ancillary-services capital expenditures declined to $42.3 million from $47.4 million. Maintenance capital expenditures increased 6.5% to $196.6 million, while development capital expenditures declined 6.3% to $74.8 million. The company had $253.6 million of free cash flow for the six months, compared with approximately $71.9 million in the prior-year period, primarily because operating cash flow improved.

Key facts

• Total operating lease right-of-use assets as of June 30, 2026: $2,430,055 and current portion of operating lease liabilities: $439,488 source
• Maintenance capital expenditures were $(197) million (current period) and $(185) million (prior period) in the free cash flow reconciliation. source
• Expenditures for property and equipment for U.S. dialysis for the six months ended June 30, 2026: $229,523 thousand source
• Total expenditures for property and equipment for the six months ended June 30, 2026: $271,836 thousand source
• Maintenance capital expenditures for the six months ended June 30, 2026: $(197) million source
• Additions of property and equipment (capital expenditures) for the six months ended June 30, 2026: $271,836 source
• Net cash used in investing activities for the six months ended June 30, 2026: $333,341 source
• Expenditures for property and equipment for Other—Ancillary services for the six months ended June 30, 2026: $42,313 thousand source

Impact estimates